Skip to navigation Skip to main content Skip to footer

Approved Research

Genomic approaches to relating cardiovascular structure and function to heart failure for the purposes of drug discovery.

Principal Investigator: Dr James Priest
Approved Research ID: 84103
Approval date: September 20th 2022

Lay summary

Tenaya Therapeutics is a  biopharmaceutical company working on discovery of new treatments for heart disease. We will look at genetic causes of heart failure, the genetic causes of how the heart functions,  and integrate this with clinical data to find new relationships between genes and heart disease. We will use this information to create new ways of treating heart disease.